DIANA REYES MACIAS: Open Payments
NPI 1043057391 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $411
Food & beverage: $228Education: $183
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $99 |
| ABBVIE INC. | 1 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Aveo Pharmaceuticals, Inc. | 1 | $23 |
| PharmaEssentia USA Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VENCLEXTA, ENHERTU, KISQALI, TECVAYLI, FOTIVDA, BESREMI, ERLEADA, VERZENIO.
Industry payments across AR — which companies pay providers there.
